Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Pharmacol ; 269(3): 325-30, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7534709

ABSTRACT

The L-type Ca2+ channel antagonist nitrendipine inhibits N-methyl-D-aspartate (NMDA)-activated Ca2+ flux into cerebellar granule cells, and [3H]dibenzocyclohepteneimine ([3H]MK 801) binding to mouse cerebral cortical and hippocampal membranes. To further study this interaction between nitrendipine and NMDA-activated channels, the effects of several L-channel active agents on [3H]MK 801 binding to mouse brain were investigated in an autoradiographic assay. Serial slide-mounted sagittal sections of mouse brain were labeled with [3H]MK 801 in the presence of varying concentrations of the L-channel active agents nitrendipine, nimodipine, nifedipine, Bay K 8644, and verapami. Nitrendipine potently displaced 2 nM [3H]MK 801 binding to mouse brain sections (IC50 = 89.8 nM). Dose-dependent inhibition of [3H]MK 801 binding by nitrendipine was demonstrated in most brain regions examined. 10(-5) M and 10(-8) M concentrations of the other dihydropyridines studied, and of verapamil, were without effect. The data supports a unique, direct interaction between nitrendipine and the NMDA-activated ion channel.


Subject(s)
Brain/drug effects , Dizocilpine Maleate/metabolism , Nitrendipine/pharmacology , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Analysis of Variance , Animals , Autoradiography , Binding, Competitive , Brain/cytology , Brain/metabolism , Calcium/metabolism , Dose-Response Relationship, Drug , Male , Mice , N-Methylaspartate/pharmacology , Nifedipine/pharmacology , Nimodipine/pharmacology , Software , Verapamil/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL